col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Association for the Advancement of Science (AAAS): Science Immunology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―25 Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Timothy A. Bates, Savannah K. McBride, Hans C. Leier, Gaelen Guzman, Zoe L. Lyski, Devin Schoen, et al. (+6)
2 [GO] 2022―Jan―07 Innate immunological pathways in COVID-19 pathogenesis Søren R. Paludan, Trine H. Mogensen
3 [GO] 2021―Nov―02 BNT162b2 vaccination induces durable SARS-CoV-2 specific T cells with a stem cell memory phenotype Gisella Guerrera, Mario Picozza, Silvia D’Orso, Roberta Placido, Marta Pirronello, Alice Verdiani, et al. (+10)
4 [GO] 2021―Oct―26 Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission Shu Horiuchi, Kohei Oishi, Lucia Carrau, Justin Frere, Rasmus Møller, Maryline Panis, Benjamin R. tenOever
5 [GO] 2021―Oct―17 SARS-CoV-2 infection generates tissue-localized immunological memory in humans Maya M.L. Poon, Ksenia Rybkina, Yu Kato, Masaru Kubota, Rei Matsumoto, Nathaniel I. Bloom, et al. (+19)
6 [GO] 2021―Oct―15 Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses Jared Feldman, Julia Bals, Clara G. Altomare, Kerri St. Denis, Evan C. Lam, Blake M. Hauser, et al. (+9)
7 [GO] 2021―Oct―14 Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity Sarah Sanchez, Nicole Palacio, Tanushree Dangi, Thomas Ciucci, Pablo Penaloza-MacMaster
8 [GO] 2021―Sep―30 Immune signatures underlying post-acute COVID-19 lung sequelae IS Cheon, C Li, YM Son, NP Goplen, Y Wu, T Cassmann, et al. (+24)
9 [GO] 2021―Sep―17 Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection Michael J. Christie, Aaron T. Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, et al. (+2)
10 [GO] 2021―Sep―14 Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue Julia Niessl, Takuya Sekine, Joshua Lange, Viktoria Konya, Marianne Forkel, Jovana Maric, et al. (+13)
11 [GO] 2021―Sep―09 Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, Stephanie Fischinger, Matthew J. Gorman, Kathryn Bowman, et al. (+36)
12 [GO] 2021―Sep―02 Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 Benjamin Israelow, Tianyang Mao, Jonathan Klein, Eric Song, Bridget Menasche, Saad B. Omer, Akiko Iwasaki
13 [GO] 2021―Aug―19 X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 Takaki Asano, Bertrand Boisson, Fanny Onodi, Daniela Matuozzo, Marcela Moncada-Velez, Majistor Raj Luxman Maglorius Renkilaraj, et al. (+101)
14 [GO] 2021―Aug―19 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, et al. (+175)
15 [GO] 2021―Aug―10 Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
16 [GO] 2021―Aug―10 Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients Samuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, Paola Gruarin, Valeria Bevilacqua, Anna Rita Putignano, et al. (+31)
17 [GO] 2021―Jul―29 Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers Shelley Klompus, Sigal Leviatan, Thomas Vogl, Roei D. Mazor, Iris N. Kalka, Liat Stoler-Barak, et al. (+14)
18 [GO] 2021―Jul―15 A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates Maria Pino, Talha Abid, Susan Pereira Ribeiro, Venkata Viswanadh Edara, Katharine Floyd, Justin C. Smith, et al. (+41)
19 [GO] 2021―Jul―09 Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in patients with COVID-19 Baweleta Isho, Kento T. Abe, Michelle Zuo, Alainna J. Jamal, Bhavisha Rathod, Jenny H. Wang, et al. (+30)
20 [GO] 2021―Jul―01 CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients Vamsee Mallajosyula, Conner Ganjavi, Saborni Chakraborty, Alana M. McSween, Ana Jimena Pavlovitch-Bedzyk, Julie Wilhelmy, et al. (+4)
21 [GO] 2021―Jul―01 Implications of defective immune responses in SARS-CoV-2 vaccinated organ transplant recipients Peter S. Heeger, Christian P. Larsen, Dorry L. Segev
22 [GO] 2021―Jun―22 COVID-19 vaccine side effects: The positives about feeling bad Jonathan Sprent, Cecile King
23 [GO] 2021―Jun―15 Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients Hector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, Fabian Halleck, Ulrike Weber, Franziska Szelinski, et al. (+19)
24 [GO] 2021―Jun―15 SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques Carolina Garrido, Alan D. Curtis, Maria Dennis, Sachi H. Pathak, Hongmei Gao, David Montefiori, et al. (+19)
25 [GO] 2021―Jun―04 Anti-body antibodies in COVID-19 Andrew H. Lichtman
26 [GO] 2021―May―25 Complement control for COVID-19 Markus Bosmann
27 [GO] 2021―May―25 SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees Daryl Geers, Marc C. Shamier, Susanne Bogers, Gerco den Hartog, Lennert Gommers, Nella N. Nieuwkoop, et al. (+19)
28 [GO] 2021―May―18 Pharmacological activation of STING blocks SARS-CoV-2 infection Minghua Li, Max Ferretti, Baoling Ying, Hélène Descamps, Emily Lee, Mark Dittmar, et al. (+14)
29 [GO] 2021―May―18 A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang, Ruth Wilson, Philip Landis, Sze-Ling Ng, et al. (+8)
30 [GO] 2021―May―13 Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection Lina Ma, Sanjaya K. Sahu, Marlene Cano, Vasanthan Kuppuswamy, Jamal Bajwa, Ja’Nia McPhatter, et al. (+25)
31 [GO] 2021―Apr―15 Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, et al. (+25)
32 [GO] 2021―Apr―14 SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients Sunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, Helle Rus Povlsen, Susana Patricia Amaya Hernandez, Morten Nielsen, et al. (+2)
33 [GO] 2021―Apr―07 SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin West, Carmen Mirabelli, et al. (+24)
34 [GO] 2021―Mar―10 Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, Felicity Liew, Clark D Russell, Shona C Moore, et al. (+20)
35 [GO] 2021―Mar―04 SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses Benedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, Luis Fernando Montaño-Gutierrez, Mark Smyth, Alexandra Popa, et al. (+37)
36 [GO] 2021―Mar―02 Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 Laura A. Vella, Josephine R. Giles, Amy E. Baxter, Derek A. Oldridge, Caroline Diorio, Leticia Kuri-Cervantes, et al. (+33)
37 [GO] 2021―Feb―23 Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients Yu Zhao, Christoph Kilian, Jan-Eric Turner, Lidia Bosurgi, Kevin Roedl, Patricia Bartsch, et al. (+32)
38 [GO] 2021―Feb―23 Prolonged evolution of the human B cell response to SARS-CoV-2 infection Mrunal Sakharkar, C. Garrett Rappazzo, Wendy F. Wieland-Alter, Ching-Lin Hsieh, Daniel Wrapp, Emma S. Esterman, et al. (+7)
39 [GO] 2021―Jan―25 Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J Chee, Benjamin J Meckiff, Hayley Simon, et al. (+5)
40 [GO] 2021―Jan―11 Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, Corinna Pade, Melanie P. Jensen, Mariana O. Diniz, et al. (+32)
41 [GO] 2020―Dec―23 Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence Gemma E. Hartley, Emily S.J. Edwards, Pei M. Aui, Nirupama Varese, Stephanie Stojanovic, James McMahon, et al. (+6)
42 [GO] 2020―Dec―08 Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, Bryan A. Stevens, Catherine A. Hogan, Javaria Najeeb, et al. (+24)
43 [GO] 2020―Dec―05 B careful: Humoral responses and COVID-19 severity Hani Fanous, Angela Guerrero-Pena, Asha Pillai
44 [GO] 2020―Nov―18 The known unknowns of T cell immunity to COVID-19 Annika C. Karlsson, Marion Humbert, Marcus Buggert
45 [GO] 2020―Oct―08 Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients Anita S. Iyer, Forrest K. Jones, Ariana Nodoushani, Meagan Kelly, Margaret Becker, Damien Slater, et al. (+29)
46 [GO] 2020―Sep―28 MAIT cell activation and dynamics associated with COVID-19 disease severity Tiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, Kimia T. Maleki, Tobias Kammann, Johanna Emgård, et al. (+15)
47 [GO] 2020―Sep―17 Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 Elizabeth R. Mann, Madhvi Menon, Sean Blandin Knight, Joanne E. Konkel, Christopher Jagger, Tovah N. Shaw, et al. (+12)
48 [GO] 2020―Aug―21 Natural killer cell immunotypes related to COVID-19 disease severity Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, Soo Aleman, Martin Cornillet, Laura Hertwig, et al. (+22)
49 [GO] 2020―Jul―29 SARS-CoV-2 seroprevalence among parturient women in Philadelphia Dustin D. Flannery, Sigrid Gouma, Miren B. Dhudasia, Sagori Mukhopadhyay, Madeline R. Pfeifer, Emily C. Woodford, et al. (+24)
50 [GO] 2020―Jul―17 SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection Daniel M. Altmann, Rosemary J. Boyton
51 [GO] 2020―Jul―15 Comprehensive mapping of immune perturbations associated with severe COVID-19 Leticia Kuri-Cervantes, M. Betina Pampena, Wenzhao Meng, Aaron M. Rosenfeld, Caroline A.G. Ittner, Ariel R. Weisman, et al. (+25)
52 [GO] 2020―Jul―10 Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 Jeong Seok Lee, Seongwan Park, Hye Won Jeong, Jin Young Ahn, Seong Jin Choi, Hoyoung Lee, et al. (+12)
53 [GO] 2020―Jul―03 Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2? Deborah Soong, Rachel Leeman, Asha Pillai
54 [GO] 2020―Jun―27 Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Alba Grifoni, Nisreen M.A. Okba, Henrik Endeman, et al. (+8)
55 [GO] 2020―Jun―11 The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut, Alena Markmann, et al. (+18)
56 [GO] 2020―Jun―05 Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 Mark Roschewski, Michail S. Lionakis, Jeff P. Sharman, Joseph Roswarski, Andre Goy, M. Andrew Monticelli, et al. (+13)
57 [GO] 2020―May―19 Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward Juliet E. Bryant, Andrew S. Azman, Matthew J. Ferrari, Benjamin F. Arnold, Maciej F. Boni, Yap. Boum, et al. (+8)
58 [GO] 2020―May―13 TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes Ruochen Zang, Maria Florencia Gomez Castro, Broc T. McCune, Qiru Zeng, Paul W. Rothlauf, Naomi M. Sonnek, et al. (+8)
59 [GO] 2020―May―08 HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19 Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
60 [GO] 2020―Apr―03 Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? Sarah E. Henrickson


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.006 sec